These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 22101555

  • 1. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.
    Trachana M, Koutsonikoli A, Farmaki E, Printza N, Tzimouli V, Papachristou F.
    Rheumatol Int; 2013 Mar; 33(3):809-13. PubMed ID: 22101555
    [Abstract] [Full Text] [Related]

  • 2. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX, Wu FQ, Wang F, Zhou ZX, Huang XL, Lu J.
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
    Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma L, Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A.
    Clin Exp Rheumatol; 2015 Sep; 33(4):449-56. PubMed ID: 26053285
    [Abstract] [Full Text] [Related]

  • 4. Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.
    Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, Toledano K, Markovits D, Rozin A, Nahir MA, Balbir-Gurman A.
    Rheumatol Int; 2013 Jun; 33(6):1495-504. PubMed ID: 23239037
    [Abstract] [Full Text] [Related]

  • 5. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J, Aguiar F, Brito I.
    Acta Reumatol Port; 2016 Jun; 41(1):45-55. PubMed ID: 27115107
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B, Li T, Guo L, Shen H, Ye S, Chen S.
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis.
    Hogan J, Godron A, Baudouin V, Kwon T, Harambat J, Deschênes G, Niel O.
    Pediatr Nephrol; 2018 Jan; 33(1):111-116. PubMed ID: 28780657
    [Abstract] [Full Text] [Related]

  • 8. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B, Lindholm C, Pullerits R.
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [Abstract] [Full Text] [Related]

  • 9. Rituximab in systemic lupus erythematosus and lupus nephritis.
    Beckwith H, Lightstone L.
    Nephron Clin Pract; 2014 Jun; 128(3-4):250-4. PubMed ID: 25471633
    [Abstract] [Full Text] [Related]

  • 10. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Gilbert M, Goilav B, Hsu JJ, Nietert PJ, Meidan E, Chua A, Ardoin SP, Wenderfer SE, von Scheven E, Ruth NM, Pediatric Nephrology and Rheumatology Collaborative Group, the Childhood Arthritis and Rheumatology Research Alliance, and the American Society for Pediatric Nephrology.
    Pediatr Rheumatol Online J; 2021 Aug 30; 19(1):137. PubMed ID: 34461932
    [Abstract] [Full Text] [Related]

  • 11. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T, Jungthirapanich J, Khositseth S.
    J Med Assoc Thai; 2010 Dec 30; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [Abstract] [Full Text] [Related]

  • 12. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep 30; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 13. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.
    Autoimmun Rev; 2010 Dec 30; 10(2):108-11. PubMed ID: 20804861
    [Abstract] [Full Text] [Related]

  • 14. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.
    Weidenbusch M, Römmele C, Schröttle A, Anders HJ.
    Nephrol Dial Transplant; 2013 Jan 30; 28(1):106-11. PubMed ID: 22764193
    [Abstract] [Full Text] [Related]

  • 15. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
    Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli FR, Spadaro A, Valesini G.
    Rheumatology (Oxford); 2011 Jun 30; 50(6):1148-52. PubMed ID: 21278072
    [Abstract] [Full Text] [Related]

  • 16. Rituximab use as induction therapy for lupus nephritis: a systematic review.
    Stolyar L, Lahita RG, Panush RS.
    Lupus; 2020 Jul 30; 29(8):892-912. PubMed ID: 32486934
    [Abstract] [Full Text] [Related]

  • 17. Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort.
    Sawhney S, Agarwal M.
    Lupus; 2021 Oct 30; 30(11):1829-1836. PubMed ID: 34315295
    [Abstract] [Full Text] [Related]

  • 18. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR, Gordon C.
    BioDrugs; 2013 Apr 30; 27(2):85-95. PubMed ID: 23456653
    [Abstract] [Full Text] [Related]

  • 19. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC, Midgley A, Carlsson E, Donohue S, Bruce IN, Beresford MW, Hedrich CM.
    RMD Open; 2020 Jul 30; 6(2):. PubMed ID: 32723832
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
    Díaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martínez-Berriotxoa A, García-Hernández F, Callejas-Rubio JL, Rascón J, D'Cruz D, Jayne D, Ruiz-Irastorza G, Emery P, Isenberg D, Ramos-Casals M, Khamashta MA, UK-BIOGEAS Registry.
    Autoimmun Rev; 2012 Mar 30; 11(5):357-64. PubMed ID: 22032879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.